Patents by Inventor Michael Frampton

Michael Frampton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8883320
    Abstract: A light emitting device comprising: an anode; a cathode; a light emissive layer located between the anode and the cathode, said light emissive layer comprising a charged metal complex for emitting light and a counterion or counterions with sufficient charge to balance the change on the charged metal complex; characterized in that the counterion or counterions are substantially immobile so (that light output from the device is immediate, provided that the combined charged metal complex and counterion do not have General Formula: (I) or (II); where C—N is a cyclometallated liquid.
    Type: Grant
    Filed: May 16, 2005
    Date of Patent: November 11, 2014
    Assignee: CDT Oxford Ltd.
    Inventors: Michael Frampton, Sophie Heidenhain, Annette Steudel, Jonthan N. G. Pillow, Scott Watkins, Nigel Male
  • Publication number: 20140221329
    Abstract: Novel mutant ESR1 molecules and uses are disclosed.
    Type: Application
    Filed: April 14, 2014
    Publication date: August 7, 2014
    Applicant: FOUNDATION MEDICINE, INC.
    Inventors: Maureen T. Cronin, Garrett Michael Frampton, Doron Lipson, Vincent A. Miller, Gary Palmer, Jeffrey S. Ross, Philip James Stephens, Roman Yelensky
  • Patent number: 8673972
    Abstract: Methods of treating a head and neck cancer are disclosed.
    Type: Grant
    Filed: August 2, 2013
    Date of Patent: March 18, 2014
    Assignees: Foundation Medicine, Inc., UCL Business PLC
    Inventors: Chris Hendrik Boshoff, Timothy Robert Fenton, Matthias Alexander Lechner, Philip James Stephens, Matthew J. Hawryluk, Roman Yelensky, Garrett Michael Frampton
  • Publication number: 20140037622
    Abstract: Methods of treating a head and neck cancer are disclosed.
    Type: Application
    Filed: August 2, 2013
    Publication date: February 6, 2014
    Applicants: UCL BUSINESS PLC, FOUNDATION MEDICINE, INC.
    Inventors: Chris Hendrik Boshoff, Timothy Robert Fenton, Matthias Alexander Lechner, Philip James Stephens, Matthew J. Hawryluk, Roman Yelensky, Garrett Michael Frampton
  • Patent number: 7740954
    Abstract: A process for modifying at least one dendron that is intended to form part of a dendrimer is disclosed. One reacts at least one reactable unsaturated group in a chemoselective manner to form a less unsaturated group. Also disclosed is a process for modifying dendrimers in a similar manner.
    Type: Grant
    Filed: August 27, 2003
    Date of Patent: June 22, 2010
    Assignees: Isis Innovation Limited, The University Court Of The University Of St. Andrews
    Inventors: Paul Leslie Burn, Ifor David William Samuel, Michael Frampton
  • Patent number: 7723553
    Abstract: A light emitting device comprising at least one compound of formula (I), (II) or (III) wherein R1 and R2, which may be the same or different, are organic substituents not including H, and wherein R3 and R5 are each independently selected from halo and organic substituents not including H, and wherein R4, R6, R7, R8, R9, and R10 are each independently selected from H, halo, and organic substituents, wherein any two or more of R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10 may optionally be fused together to form a ring system, provided that one of R3 and R5 is not part of a fused ring system, and provided that R1 and R2 are not fused to each other to form a ring system, and wherein one but not both of either (a) R3 and R4, or (b) R5 and R6, are fused to each other to form a ring system.
    Type: Grant
    Filed: September 12, 2006
    Date of Patent: May 25, 2010
    Assignee: CDT Oxford Limited
    Inventors: Jonathan N. G. Pillow, Michael Frampton
  • Publication number: 20080176104
    Abstract: An electroluminescent device comprising:—a first electrode for injection of positive charge carriers;—a second electrode for injection of negative charge carriers; and—an electroluminescent layer located between the first and second electrodes comprising a host material and a metal complex, wherein the host material comprises a polymer having a first repeat unit of formula (I): wherein each Ar is the same or different and independently represents an optionally substituted aryl or heteroaryl and any two Ar groups may be directly linked by a single bond.
    Type: Application
    Filed: August 2, 2004
    Publication date: July 24, 2008
    Applicants: CDT Oxford Limited, Cambridge Display Technology Limited
    Inventors: Carl Towns, Ilaria Grizzi, Stephen O'Connor, Annette Steudel, Jonathan Pillow, Michael Frampton
  • Publication number: 20080036368
    Abstract: A light emitting device comprising: an anode; a cathode; a light emissive layer located between the anode and the cathode, said light emissive layer comprising a charged metal complex for emitting light and a counterion or counterions with sufficient charge to balance the charge on the charged metal complex; characterised in that the counterion or counterions are substantially immobile so that light output from the device is immediate, provided that the combined charged metal complex and counterion do not have General Formula I or II: where C—N is a cyclometallated ligand.
    Type: Application
    Filed: May 16, 2005
    Publication date: February 14, 2008
    Applicant: CDT OXFORD LTD.
    Inventors: Michael Frampton, Sophie Heidenhain, Annette Steudel, Jonthan Pillow, Scott Watkins, Nigel Male
  • Publication number: 20070073093
    Abstract: A light emitting device comprising at least one compound of formula (I), (II) or (III) wherein R1 and R2, which may be the same or different, are organic substituents not including H, and wherein R3 and R5 are each independently selected from halo and organic substituents not including H, and wherein R4, R6, R7, R8, R9, and R10 are each independently selected from H, halo, and organic substituents, wherein any two or more of R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10 may optionally be fused together to form a ring system, provided that one of R3 and R5 is not part of a fused ring system, and provided that R1 and R2 are not fused to each other to form a ring system, and wherein one but not both of either (a) R3 and R4, or (b) R5 and R6, are fused to each other to form a ring system.
    Type: Application
    Filed: September 12, 2006
    Publication date: March 29, 2007
    Applicant: CDT OXFORD LTD.
    Inventors: Jonathan Pillow, Michael Frampton
  • Publication number: 20050164029
    Abstract: A process for modifying at least one dendron that is intended to form part of a dendrimer is disclosed. One reacts at least one reactable unsaturated group in a chemoselective manner to form a less unsaturated group. Also disclosed is a process for modifying dendrimers in a similar manner.
    Type: Application
    Filed: August 27, 2003
    Publication date: July 28, 2005
    Inventors: Paul Burn, Ifor Samuel, Michael Frampton
  • Publication number: 20050042475
    Abstract: There is disclosed a light emitting device comprising at least one compound of formula (I), (II) or (III) wherein R1 and R2, which may be the same or different, are organic substituents not including H, and wherein R3 and R5 are each independently selected from halo and organic substituents not including H, and wherein R4, R6, R7, R8, R9, and R10 are each independently selected from H, halo, and organic substituents, wherein any two or more of R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10 may optionally be fused together to form a ring system, provided that one of R3 and R5 is not part of a fused ring system, and provided that R1 and R2 are not fused to each other to form a ring system, and wherein one but not both of either (a) R3 and R4, or (b) R5 and R6, are fused to each other to form a ring system.
    Type: Application
    Filed: November 15, 2002
    Publication date: February 24, 2005
    Inventors: Jonathan Pillow, Michael Frampton